Condition
Gastrointestinal Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Gastrointestinal Tumors clinical trials that are recruiting, at sites in 2 countries (most in China (10), United States (1)). By phase: Phase 1 (4), Phase 2 (3), Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 2Countries
Newest Gastrointestinal Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BL-M08D in patients with digestive tract and other solid tumors | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Aug 21, 2026 |
| BL-ARC002 in patients with advanced solid tumors | Phase 1 | Guangzhou, Guangdong | Recruiting | Aug 13, 2026 |
| Gastrointestinal cancer screening using a multi-target detection model | — | Zhaoqing, Guangdong and 5 other locations | Recruiting | Jul 17, 2026 |
| SKB571 in Gastrointestinal Tumors | Phase 2 | Chongqing, Chongqing Municipality and 25 other locations | Recruiting | May 4, 2026 |
| KQB198 plus imatinib for first-line advanced or metastatic GIST | Phase 2 | Los Angeles, California and 16 other locations | Recruiting | Feb 12, 2026 |
| BL-M24D1 treatment for advanced gastrointestinal and other solid tumors | Phase 1 | Beijing, Beijing Municipality | Recruiting | Dec 12, 2025 |
| Lutetium‑177 BL‑ARC001 for advanced or metastatic gastrointestinal and other solid tumors | Phase 1 | Chengdu, Sichuan | Recruiting | Nov 18, 2025 |
| Personalized mRNA neoantigen vaccine plus anti-PD-1 for gastrointestinal tumors | Phase 1 | Shanghai, SH | Recruiting | Jul 16, 2025 |
| Using Propranolol for Patients with Gastrointestinal Tumors Before Surgery | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jan 14, 2025 |
| Screening for gastrointestinal tumors in patients | — | Jinhua, Zhejiang and 1 other locations | Recruiting | Jun 27, 2024 |
All recruiting trials (11)
-
BL-M08D in patients with digestive tract and other solid tumors
A early-stage study to see if BL-M08D1 can be safely given and help people with advanced digestive tract cancers and other solid tumors.
-
BL-ARC002 in patients with advanced solid tumors
This study tests BL-ARC002 to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors.
-
Gastrointestinal cancer screening using a multi-target detection model
A randomized trial tests whether a combined blood and stool screening approach can reduce 5-year gastrointestinal cancer deaths compared with standard routine observation.
-
SKB571 in Gastrointestinal Tumors
A Phase 2, open-label study tests SKB571 in adults with gastrointestinal tumors to see if it is safe and may help shrink tumors.
-
KQB198 plus imatinib for first-line advanced or metastatic GIST
This Phase 2 test will see if adding the experimental drug KQB198 to imatinib helps people with advanced or metastatic GIST who are starting first-line treatment.
-
BL-M24D1 treatment for advanced gastrointestinal and other solid tumors
This trial will test BL-M24D1 in adults with locally advanced or metastatic gastrointestinal and other solid tumors to see if it is safe, tolerated, and shows early signs of anti-tumor activity.
-
Lutetium‑177 BL‑ARC001 for advanced or metastatic gastrointestinal and other solid tumors
This trial will test whether Lutetium‑177 BL‑ARC001 is safe and shows early benefit in adults with locally advanced or metastatic gastrointestinal or other solid tumors.
-
Personalized mRNA neoantigen vaccine plus anti-PD-1 for gastrointestinal tumors
This trial will test a personalized mRNA neoantigen vaccine given with sintilimab to see if it helps adults with advanced or high-risk resected gastrointestinal cancers.
-
Using Propranolol for Patients with Gastrointestinal Tumors Before Surgery
This study is testing if giving propranolol, a beta-blocker, to patients with gastrointestinal tumors before surgery can help reduce stress and improve outcomes.
-
Screening for gastrointestinal tumors in patients
This study is trying to see if a series of tests and questionnaires can help identify people at high risk for gastrointestinal tumors so they can get the right screenings and care.
-
BGT007H cell therapy for treating recurrent gastrointestinal tumors
This study is testing a new cell therapy called BGT007H to see if it is safe and effective for people with recurrent gastrointestinal tumors.
Related topics
Quick answers
How many Gastrointestinal Tumors clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (10 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 2: 3, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.